These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19347990)

  • 1. Side-effects and venous access issues with immune tolerance therapy.
    Carcao MD
    Haemophilia; 2009 Mar; 15(2):494-500. PubMed ID: 19347990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
    Komvilaisak P; Connolly B; Naqvi A; Blanchette V
    Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study.
    Rodriguez V; Mancuso ME; Warad D; Hay CR; DiMichele DM; Valentino L; Kenet G; Kulkarni R
    Haemophilia; 2015 Sep; 21(5):e369-74. PubMed ID: 26178581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus recommendations for use of central venous access devices in haemophilia.
    Ewenstein BM; Valentino LA; Journeycake JM; Tarantino MD; Shapiro AD; Blanchette VS; Hoots WK; Buchanan GR; Manco-Johnson MJ; Rivard GE; Miller KL; Geraghty S; Maahs JA; Stuart R; Dunham T; Navickis RJ
    Haemophilia; 2004 Sep; 10(5):629-48. PubMed ID: 15357790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia.
    Ranta S; Kalajoki-Helmiö T; Pouttu J; Mäkipernaa A
    Haemophilia; 2012 Jul; 18(4):521-6. PubMed ID: 22176603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical issues in inhibitors.
    Astermark J; Santagostino E; Keith Hoots W
    Haemophilia; 2010 Jul; 16 Suppl 5():54-60. PubMed ID: 20590857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome.
    McMahon C; Smith J; Khair K; Liesner R; Hann IM; Smith OP
    Br J Haematol; 2000 Aug; 110(2):461-8. PubMed ID: 10971409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of infectious complications associated with central venous access devices in children with haemophilia.
    Tarantino MD; Lail A; Donfield SM; Lynn H; Peddle L; Hunsberger S; Shapiro AD
    Haemophilia; 2003 Sep; 9(5):588-92. PubMed ID: 14511299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland.
    Vepsäläinen K; Lassila R; Arola M; Lähteenmäki P; Möttönen M; Mäkipernaa A; Riikonen P
    Haemophilia; 2015 Nov; 21(6):747-53. PubMed ID: 25832453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous access devices in patients with hemophilia.
    Valentino LA; Kapoor M
    Expert Rev Med Devices; 2005 Nov; 2(6):699-711. PubMed ID: 16293097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central venous access device-related infections in patients with haemophilia.
    Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
    J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITT.
    Barnes C; Rivard GE; Poon MC; Teitel J; Pai M; Kern M; Blanchette VS; Carcao M;
    Haemophilia; 2006 Jan; 12(1):1-6. PubMed ID: 16409169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue plasminogen activator may reduce frequency of central venous access device infection in hemophilia patients undergoing immune tolerance therapy.
    Dunn AL; Abshire TC
    Pediatr Blood Cancer; 2008 Mar; 50(3):627-9. PubMed ID: 17143876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors.
    DiMichele DM; Kroner BL;
    Thromb Haemost; 2002 Jan; 87(1):52-7. PubMed ID: 11848456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
    Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
    Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient central venous access device insertion in very young children with severe haemophilia.
    Bensadok H; Maniora M; Théron A; Jeziorski E; Rochette A; Navarro R; Schved JF; Champiat MA; Biron-Andreani C
    Blood Coagul Fibrinolysis; 2020 Oct; 31(7):490-492. PubMed ID: 32941198
    [No Abstract]   [Full Text] [Related]  

  • 17. Central venous access devices in haemophilia.
    Valentino LA; Ewenstein B; Navickis RJ; Wilkes MM
    Haemophilia; 2004 Mar; 10(2):134-46. PubMed ID: 14962202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of central venous access devices in paediatric haemophilia patients.
    Domm JA; Hudson MG; Janco RL
    Haemophilia; 2003 Jan; 9(1):50-6. PubMed ID: 12558778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in the treatment of high responding inhibitors in severe haemophilia A.
    Moschovi M; Aronis S; Trimis G; Platokouki H; Salavoura K; Tzortzatou-Stathopoulou F
    Haemophilia; 2006 Jan; 12(1):95-9. PubMed ID: 16409183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
    Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
    Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.